Verbavox Group supports pharma companies, biotech, CROs and life-sciences organisations with regulated, audit-ready translations. From clinical trial protocols to drug labelling and pharmacovigilance, our linguists combine scientific accuracy with full regulatory awareness — EMA, FDA, MHRA and beyond.
End-to-end multilingual support across the drug lifecycle, from R&D to post-marketing.
We follow ISO 17100 and life-sciences best practice (back-translation, reconciliation, linguistic validation) to meet the standards of regulators and ethics committees in every market.
Linguists trained on EMA, FDA and ICH terminology and submission standards.
Back-translation, reconciliation and cognitive debriefing for PROs and ICFs.
NDAs, secure environments and full audit trail for sensitive trial data.
Yes — full back-translation, reconciliation and cognitive debriefing for PROs, ICFs and patient-facing materials.
Yes. Two-step linguist review, qualified subject-matter experts and full project traceability.
Our linguists are familiar with eCTD modules, SmPC/PIL/labelling templates and regional regulatory requirements.
We work natively with Word, Excel, PowerPoint and PDF. For more complex formats please send the files by email so we can review them and confirm feasibility.
Yes — NDAs are signed by default and we work in encrypted environments for sensitive data.
Tell us about your project and we'll match you with the right specialist team within one business day.
Get a tailored consultation